In this issue:
Global burden of COPD through 2050
Early evidence of COPD can be obscured by race-specific prediction equations
Lung ultrasound assessment of lung hyperinflation
Impact of undiagnosed COPD and asthma on quality of life, healthcare use, and work productivity
Initiating MVPA after COPD diagnosis has survival benefits
Eligibility of COPD patients for inclusion in RCTs investigating triple therapy
Dupilumab for COPD with type 2 inflammation
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care
Risk of cardiovascular events and death after AECOPD
Palliative care approaches in patients with COPD, heart failure or interstitial lung disease
Please login below to download this issue (PDF)